Results 161 to 170 of about 1,716,661 (233)

Chimeric antigen receptor T-cells in multiple myeloma: Present and future [PDF]

This is a brief summary of various general contemporary topics regarding chimeric antigen receptor (CAR) T-cells in multiple myeloma (MM)
Plata, Carlos
core  

Real-world prevalence and prognostic significance of hepatotoxicity after chimeric antigen receptor T-cell therapy. [PDF]

Br J Haematol
Hollnberger J, Richardson T, Gödel P, Leutiger J, Schumacher JC, Schiestel S, Allhoff B, Scheid C, Holtick U, Neumann-Haefelin C, Allo G, Kasper P.   +11 more
europepmc   +1 more source

Real-world outcomes for multiple myeloma patients after apheresis for planned chimeric antigen receptor T-cell therapy. [PDF]

World J Exp Med
Bangolo A, Gill S, Zhang L, Zhao J, Amoozgar B, Reich-Slotky R, Tran J, Vo T, Mariblanca G, Balulescu X, Mcknight S, Patel N, Reed A, Kaur S, Subramanian S, Katyal J, Manikkuttiyil C, Chakov M, Nguyen A, Pashine S, Khalil A, Mathew S, Gill R, Andrews V, Ordonez P, Olson B, Koleng M, Persaud R, Saride HS, Dharsi M, Thach R, Chen W, Shahid M, Weissman S, Siegel D, Parmar H, Biran N, Vesole DH, Phull P.   +38 more
europepmc   +1 more source

The role and potential of CD19-targeted chimeric antigen receptor T-cell therapy in systemic sclerosis. [PDF]

Reumatologia
Michalak K, Chlebowska G, Sędziak O, Woszczyk D.   +3 more
europepmc   +1 more source

The dilemma after chimeric antigen receptor T-cell therapy - to transplant or not? [PDF]

Haematologica
Jacoby E, Bielorai B.
europepmc   +1 more source

Oncofetal antigens as emerging targets in chimeric antigen receptor (CAR)-T cell-based immunotherapies: opportunities and challenges. [PDF]

Front Cell Dev Biol
Smith SS, Klampatsa A.
europepmc   +1 more source

Neurological implications of chimeric antigen receptor-T cell therapy. [PDF]

BMJ Neurol Open
Raffoul DG, Roos I, Mulazzani M, Anderson MA, Monif M, Garber J, van der Walt A, Massey J, Kuznetsova V, Nesbitt C, Dowling M, Ruderman I, Lasocki A, Tam CS, Harrison SJ, Kalincik T.   +15 more
europepmc   +1 more source

Changes in C-Reactive Protein Forecast Infection Risk Following Treatment with Chimeric Antigen Receptor T Cells. [PDF]

Cancers (Basel)
Mathur P, Chen H, Riedel DJ, Holland E, Palacio D, Bork JT, Prakash K, Hardy N, Kocoglu M, Badros A, Fromowitz A, Yared J, Rapoport AP, Atanackovic D, Baddley J.   +14 more
europepmc   +1 more source

A Review of Recent Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hepatocellular Carcinoma. [PDF]

Med Sci Monit
Lv X, Chen X, Ge Y, Si G, Li Y, Li X, Yuan X.   +6 more
europepmc   +1 more source

Development and characterization of chimeric antigen receptor macrophages for amyloid clearance. [PDF]

Front Immunol
Balachandran M, Foster JS, Hancock TJ, Martin EB, Jackson JW, Angell N, Wall JS.   +6 more
europepmc   +1 more source